Pharmacotherapeutic Group: Antimycotics for systemic use, Triazole derivatives;
Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. The accumulation of 14 alpha-methyl sterols correlates with the subsequent loss of ergosterol in the fungal cell membrane and may be responsible for the antifungal activity of fluconazole
Paediatric population
A maximum dose of 400 mg daily should not be exceeded in paediatric population.
As with similar infections in adults, the duration of treatment is based on the clinical and mycological response. Fluconazole is administered as a single daily dose
- Oropharyngeal Candidiasis
- Esophageal Candidiasis
- Cryptococcal Meningitis
- Prevention of candidiasis incidence in patients undergoing bone marrow transplant
- Vaginal Candidiasis
- Candida UTI/Peritonitis
Tresi Farm sh.p.k profiled itself as the primary pharmaceutical distributor that has the main focus in importing, marketing and distribution of products which enjoys exclusive rights from contracts signed with partners outside the Republic of Albania.